Corcept Therapeutics (CORT) Posts Wider than Expected Q4 loss of 12c/Share
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $79.91 -2.25%
Revenue Growth %: +12.1%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +12.1%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q4 EPS of ($0.12), $0.03 worse than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
- Rochon family buys $100M in AIAI Holdings shares at $20 each
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
